Blockchain Registration Transaction Record

Branded Legacy Files Patent for Revolutionary Intranasal Drug Delivery Device

Branded Legacy files patent for innovative air-powered intranasal drug delivery device designed for precise dosing of medications including naloxone and unstable formulations requiring reconstitution.

This development represents a significant advancement in medical technology that could transform emergency response and routine medication administration. The air-powered intranasal delivery device addresses critical gaps in current drug delivery systems, particularly for life-saving medications like naloxone used in opioid overdose situations. By enabling precise, reliable dosing for both stable and unstable formulations, this technology could improve treatment outcomes, reduce medication errors, and make emergency interventions more accessible. In the context of the ongoing opioid crisis and growing need for efficient drug delivery systems, this innovation has the potential to save lives and improve healthcare efficiency across multiple therapeutic areas.